Senior Biotechnologist

OXB; Oxford; On-site; GBP 60,000 - 80,000; Full time

Job summary

A leading biotechnology firm is seeking a Senior Biotechnologist to coordinate daily production activities in GMP viral vector manufacturing. The successful candidate will ensure compliance with GMP standards, train team members, and contribute to the production of scalable therapeutic vectors. This role offers a chance to be part of a mission-driven team dedicated to life-changing therapies.

Benefits

Competitive total reward packages

Wellbeing programmes

Career development opportunities

Inclusive and collaborative culture

State-of-the-art labs

Qualifications

• A degree in a science-based subject or relevant experience.
• Experience in a regulated environment.
• Strong knowledge of GMP procedures.

Responsibilities

• Support daily production activities in viral vector manufacturing.
• Conduct training for core manufacturing activities.
• Ensure compliance with GMP procedures.

Skills

GMP standards

Biological manufacturing experience

Aseptic environment

GMP audits

QI, CAPA and Change Controls

Education

Degree in a science-based subject

Job description

Job description:

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

We’re currently recruiting for a Senior Biotechnologist to join our Manufacturing team. In this role, you will support the Team Lead by coordinating the team’s daily production activities and contributing to the manufacturing of GMP viral vectors, playing a key part in advancing our mission and making a real difference.

Your responsibilities

• Taking accountability, as part of a team of Biotechnologists, for the successful manufacture of viral vector batches
• Ensuring that all work within the manufacturing facility is carried out in compliance with the facilities GMP procedures
• Acting as a Subject Matter Expert (SME) for facility SOPs and batch documentation
• Leading upstream and downstream manufacturing processes within the GMP facility
• Training others on core manufacturing activities
• Participating in the revision of GMP documentation

We are Looking For

• A degree in a science-based subject, and/or experience of working to GMP standards
• Previous biological/chemical manufacturing experience in an MHRA /FDA regulated environment
• Experience working in an Aseptic environment
• Strong knowledge of GMP audits, QI, CAPA and Change Controls

About Us

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us

• Competitive total reward packages
• Wellbeing programmes that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State-of-the-art labs and manufacturing facilities
• A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.